Türk Medline
ADR Yönetimi
ADR Yönetimi

RESCUE ARTERIAL REVASCULARIZATION USING CRYOPRESERVED ILIAC ARTERY ALLOGRAFT IN LIVER TRANSPLANT PATIENTS

KAYVAN MOHKAM, BENJAMİN DARNİS, AGNÈS RODE, NATHALİE HETSCH, GREGORİO BALBO, JEAN-PAUL BOURGEOT, SALİM MEZOUGHİ, HASSAN DEMİAN, CHRİSTİAN DUCERF, JEAN-YVES MABRUT

Experimental and Clinical Transplantation - 2017;15(4):420-424

From the Department of General Surgery and Liver Transplantation and the Department of Medical Imaging and Interventional Radiology, Hospices Civils de Lyon, Croix-Rousse University Hospital, Lyon, France

 

Objectives: Management of hepatic arterial com¬plications after liver transplant remains challenging. The aim of our study was to assess the efficacy of rescue arterial revascularization using cryopreserved iliac artery allografts in this setting. Materials and Methods: Medical records of patients with liver transplants who underwent rescue arterial revascularization using cryopreserved iliac artery allografts at a single institution were reviewed. Results: From 1992 to 2015, 7 patients underwent rescue arterial revascularization using cryopreserved iliac artery allografts for hepatic artery pseudo¬aneurysm (3 patients), thrombosis (2 patients), aneurysm (1 patient), or stenosis (1 patient). Two patients developed severe complications, comprising one biliary leakage treated percutaneously, and one acute necrotizing pancreatitis causing death on postoperative day 29. After a median follow-up of 75 months (range, 1-269 mo), 2 patients had an uneventful long-term course, whereas 4 patients developed graft thrombosis after a median period of 120 days (range, 2-488 d). Among the 4 patients who developed graft thrombosis, 1 patient developed ischemic cholangitis, 1 developed acute ischemic hepatic necrosis and was retransplanted, and 2 patients did not develop any further complications. Conclusions: Despite a high rate of allograft thrombosis, rescue arterial revascularization using cryopreserved iliac artery allografts after liver transplant is an effective and readily available approach, with a limited risk of infection and satisfactory long-term graft and patient survival.